Curebase Solutions Supports Another InBios FDA Emergency Use Authorisation for COVID-19 IgG Antibody Rapid Test
The InBios test includes all reagents and controls required to run 50 test specimens with results in approximately…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Oct 21
The InBios test includes all reagents and controls required to run 50 test specimens with results in approximately…
30 Sep 21
The collaboration will initially use machine learning to identify correlations in molecular and imaging readings to differentiate lung…
29 Sep 21
The merger that values LumiraDx at $3bn enables it to become publicly traded company
29 Sep 21
Selux claims that NGP is the only single-platform technology capable of delivering rapid AST results across all sample…
28 Sep 21
OmniGraf is claimed to be the only combination biomarker panel that offers the earliest indication of rejection in…
28 Sep 21
ANP’s NIDS Covid-19 test detects SARS-CoV-2 nucleocapsid protein in nasal swab specimens and provides the result within 15…
24 Sep 21
The Series C funding will help the company to significantly invest in its platform and support the development…
23 Sep 21
Designed to run on cobas 6800/8800 systems, the three molecular PCR diagnostic test panels will facilitate the detection…
21 Sep 21
Applied Biosystems QuantStudio Absolute Q Digital PCR System*, the first integrated digital PCR solution, is ideal for oncology,…
21 Sep 21
The standard set by New York State represents one of the most rigorous levels of validation required for…